Seguin Philippe, Bellissant Eric, Le Tulzo Yves, Laviolle Bruno, Lessard Yvon, Thomas Rémy, Mallédant Yannick
Service de Réanimation Chirurgicale, Hôpital de Pontchaillou, 2 Rue Henri Le Gailloux, Université de Rennes I, 35033 Rennes Cedex, France.
Clin Pharmacol Ther. 2002 May;71(5):381-8. doi: 10.1067/mcp.2002.122471.
In septic shock, the alteration of the gut barrier contributes to the development of multiple organ failure. The aim of the study was to compare epinephrine with the combination of dobutamine and norepinephrine on gastric perfusion in patients with septic shock.
In a prospective randomized study on 2 parallel groups, systemic and pulmonary hemodynamics (arterial and Swan-Ganz catheters), gastric mucosal blood flow (laser Doppler flowmetry technique), hepatic function (indocyanine green clearance), and blood gases were evaluated just before catecholamine infusion and when mean arterial pressure reached 70 to 80 mm Hg. Epinephrine or norepinephrine were titrated (from 0.1 microg/kg per minute, with 0.2 microg/kg per minute increases every 5 minutes). Dobutamine was continuously infused at 5 microg/kg per minute.
Twenty-two patients were included (11 in each group). At randomization there was no significant difference between groups. At the time of evaluation, mean arterial pressure was 78 +/- 3 and 77 +/- 5 mm Hg in the epinephrine and dobutamine-norepinephrine groups, respectively. There was no significant difference between groups regardless of the systemic and pulmonary hemodynamic or blood gas variable considered. Nevertheless, compared with dobutamine-norepinephrine, epinephrine tended to induce greater values for cardiac index (5.0 +/- 1.6 versus 4.2 +/- 1.5 L/min per square meter; P =.078) and oxygen transport (617 +/- 166 versus 481 +/- 229 mL/min per square meter; P =.068). Epinephrine also induced significantly greater values of gastric mucosal blood flow (662 +/- 210 versus 546 +/- 200 units; P =.011) but did not modify indocyanine green clearance.
In patients with septic shock, at doses that induced the same mean arterial pressure, epinephrine enhanced more gastric mucosal blood flow than the combination of dobutamine at 5 microg/kg per minute and norepinephrine. This effect was probably a result of higher cardiac index.
在感染性休克中,肠道屏障的改变会促使多器官功能衰竭的发生。本研究旨在比较肾上腺素与多巴酚丁胺和去甲肾上腺素联合应用对感染性休克患者胃灌注的影响。
在一项针对两个平行组的前瞻性随机研究中,在儿茶酚胺输注前以及平均动脉压达到70至80 mmHg时,评估全身和肺血流动力学(动脉导管和 Swan-Ganz 导管)、胃黏膜血流(激光多普勒血流仪技术)、肝功能(吲哚菁绿清除率)和血气。肾上腺素或去甲肾上腺素进行滴定(从0.1微克/千克每分钟开始,每5分钟增加0.2微克/千克每分钟)。多巴酚丁胺以5微克/千克每分钟的速度持续输注。
纳入22例患者(每组11例)。随机分组时两组之间无显著差异。在评估时,肾上腺素组和多巴酚丁胺-去甲肾上腺素组的平均动脉压分别为78±3和77±5 mmHg。无论考虑全身和肺血流动力学或血气变量,两组之间均无显著差异。然而,与多巴酚丁胺-去甲肾上腺素相比,肾上腺素倾向于使心脏指数(5.0±1.6对4.2±1.5升/分钟每平方米;P = 0.078)和氧输送(617±166对481±229毫升/分钟每平方米;P = 0.068)的值更高。肾上腺素还使胃黏膜血流值显著更高(662±210对546±200单位;P = 0.011),但未改变吲哚菁绿清除率。
在感染性休克患者中,在诱导相同平均动脉压的剂量下,肾上腺素比5微克/千克每分钟的多巴酚丁胺和去甲肾上腺素联合应用能增强更多的胃黏膜血流。这种效应可能是更高心脏指数的结果。